GOLDSPIRE

Serial Number 97597040
Registration 7545537
700

Registration Progress

Application Filed
Sep 19, 2022
Under Examination
Apr 9, 2024
Approved for Publication
Feb 13, 2024
Published for Opposition
Feb 13, 2024
Registered
Oct 22, 2024

Trademark Image

GOLDSPIRE

Basic Information

Serial Number
97597040
Registration Number
7545537
Filing Date
September 19, 2022
Registration Date
October 22, 2024
Published for Opposition
February 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 22, 2024
Registration
Registered
Classes
042

Rights Holder

Imvax, Inc.

03
Address
601 Walnut Street, Suite 440
Philadelphia, PA 19106

Ownership History

Imvax, Inc.

Original Applicant
03
Philadelphia, PA

Imvax, Inc.

Owner at Publication
03
Philadelphia, PA

Imvax, Inc.

Original Registrant
03
Philadelphia, PA

Legal Representation

Attorney
Zachary J. Holdsman

USPTO Deadlines

Next Deadline
1731 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241022)
Due Date
October 22, 2030
Grace Period Ends
April 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Oct 22, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 22, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 19, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 19, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 30, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 9, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 30, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 9, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 13, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 4, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 4, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 16, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Nov 16, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 16, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Nov 16, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 16, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 16, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 16, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research, design and development of personalized whole tumor-derived cell-based autologous immunotherapies for the treatment of cancers; providing a proprietary technology platform for the development of pharmaceutical products and devices featuring technology capable of eliciting anti-tumor responses via the release of tumor antigenic signatures and immunostimulatory factors that activate the adaptive immune system against tumor cells
First Use Anywhere: Dec 5, 2022
First Use in Commerce: Dec 5, 2022

Additional Information

Pseudo Mark
GOLD SPIRE

Classification

International Classes
042